Filter your results
- 2
- 1
- 3
- 3
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective studyRheumatology, 2021, pp.keab116. ⟨10.1093/rheumatology/keab116⟩
Journal articles
pasteur-03236464v1
|
||
|
Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 InfectionJournal of Clinical Immunology, 2022, 42 (1), pp.25-27. ⟨10.1007/s10875-021-01119-y⟩
Journal articles
hal-03683669v1
|
||
|
A child with severe juvenile dermatomyositis treated with ruxolitinibBrain - A Journal of Neurology , 2018, 141 (11), pp.e80. ⟨10.1093/brain/awy255⟩
Journal articles
pasteur-01963025v1
|